Yushi Liu

3.5k total citations
100 papers, 1.9k citations indexed

About

Yushi Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yushi Liu has authored 100 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Yushi Liu's work include Epigenetics and DNA Methylation (11 papers), RNA modifications and cancer (8 papers) and Systemic Lupus Erythematosus Research (5 papers). Yushi Liu is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), RNA modifications and cancer (8 papers) and Systemic Lupus Erythematosus Research (5 papers). Yushi Liu collaborates with scholars based in China, United States and Denmark. Yushi Liu's co-authors include Steven A. Belinsky, Shannon Bruse, Jian Li, Yohannes Tesfaigzi, Li Guo, Shuguang Leng, J. A. Cowan, Christin M. Yingling, Mathewos Tessema and Maria A. Picchi and has published in prestigious journals such as Nucleic Acids Research, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yushi Liu

96 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yushi Liu China 27 837 255 224 223 198 100 1.9k
Lihua Xie China 28 991 1.2× 313 1.2× 179 0.8× 189 0.8× 243 1.2× 133 2.3k
Zhiqiang Huang China 30 764 0.9× 272 1.1× 230 1.0× 222 1.0× 140 0.7× 140 2.4k
Liqun Huang China 26 742 0.9× 125 0.5× 199 0.9× 197 0.9× 145 0.7× 143 2.3k
Xiaonan Wu China 22 1.1k 1.3× 204 0.8× 147 0.7× 322 1.4× 130 0.7× 61 1.9k
Jaromír Mikeš Slovakia 27 843 1.0× 521 2.0× 239 1.1× 185 0.8× 165 0.8× 65 2.4k
Jin Huang China 26 903 1.1× 216 0.8× 348 1.6× 91 0.4× 273 1.4× 143 2.2k
Dan Qi China 25 784 0.9× 113 0.4× 117 0.5× 167 0.7× 209 1.1× 101 1.7k
Juan Tang China 29 1.2k 1.4× 178 0.7× 146 0.7× 237 1.1× 306 1.5× 110 2.5k
Shuyang Chen China 20 951 1.1× 100 0.4× 148 0.7× 266 1.2× 346 1.7× 85 1.9k

Countries citing papers authored by Yushi Liu

Since Specialization
Citations

This map shows the geographic impact of Yushi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yushi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yushi Liu more than expected).

Fields of papers citing papers by Yushi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yushi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yushi Liu. The network helps show where Yushi Liu may publish in the future.

Co-authorship network of co-authors of Yushi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yushi Liu. A scholar is included among the top collaborators of Yushi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yushi Liu. Yushi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yushi, Jiawen Song, Sihui Li, et al.. (2025). Synergistic therapy with celastrol-curcumin multifunctional nanomedicine: Anti-hepatocellular carcinoma and reduced hepatotoxicity. International Journal of Pharmaceutics. 671. 125289–125289. 3 indexed citations
3.
Yuan, Minghao, et al.. (2024). Therapeutic effects and molecular mechanisms of natural products in thrombosis. Phytotherapy Research. 38(5). 2128–2153. 1 indexed citations
4.
Song, Jiawen, et al.. (2024). Study on the Hepatotoxicity of Emodin and Its Application in the Treatment of Liver Fibrosis. Molecules. 29(21). 5122–5122. 2 indexed citations
5.
Wang, Yafang, Yushi Liu, Yiqi Wan, et al.. (2023). A 3-Ketoacyl-CoA Synthase 10 (KCS10) Homologue from Alfalfa Enhances Drought Tolerance by Regulating Cuticular Wax Biosynthesis. Journal of Agricultural and Food Chemistry. 71(40). 14493–14504. 19 indexed citations
7.
Thyssen, Jacob P., Diamant Thaçi, Thomas Bieber, et al.. (2023). Upadacitinib for moderate‐to‐severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics. Journal of the European Academy of Dermatology and Venereology. 37(9). 1871–1880. 11 indexed citations
8.
Liu, Wan‐Qiu, et al.. (2022). Cell-free expression of NO synthase and P450 enzyme for the biosynthesis of an unnatural amino acid L-4-nitrotryptophan. Synthetic and Systems Biotechnology. 7(2). 775–783. 23 indexed citations
9.
Ba, Fang, et al.. (2022). SYMBIOSIS: synthetic manipulable biobricks via orthogonal serine integrase systems. Nucleic Acids Research. 50(5). 2973–2985. 18 indexed citations
10.
Liu, Yushi, Wan‐Qiu Liu, Shuhui Huang, et al.. (2022). Cell-free metabolic engineering enables selective biotransformation of fatty acids to value-added chemicals. Metabolic Engineering Communications. 16. e00217–e00217. 14 indexed citations
11.
Zhang, Ya, Weizhong Chen, Di Wu, et al.. (2022). Molecular basis for cell-wall recycling regulation by transcriptional repressor MurR in Escherichia coli. Nucleic Acids Research. 50(10). 5948–5960. 8 indexed citations
12.
Yuan, Minghao, Sheng Gong, Yushi Liu, et al.. (2022). Rapid discrimination of the authenticity and geographical origin of bear bile powder using stable isotope ratio and elemental analysis. Analytical and Bioanalytical Chemistry. 415(2). 345–356. 6 indexed citations
13.
Huang, Shuhui, Yushi Liu, Wan‐Qiu Liu, Peter Neubauer, & Jian Li. (2021). The Nonribosomal Peptide Valinomycin: From Discovery to Bioactivity and Biosynthesis. Microorganisms. 9(4). 780–780. 45 indexed citations
14.
Lin, Chunxiang, et al.. (2021). Carboxylated cellulose nanocrystals with chiral nematic property from cotton by dicarboxylic acid hydrolysis. Carbohydrate Polymers. 264. 118039–118039. 23 indexed citations
15.
Li, Jianyi, Jia Shi, Yang Zhang, et al.. (2021). Long-term tracing and staining of carbon nanoparticles for axillary lymph nodes in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy. Asian Journal of Surgery. 45(1). 89–96. 8 indexed citations
16.
Leng, Shuguang, Guodong Wu, Leonard B. Collins, et al.. (2015). Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung. Cancer Research. 75(15). 3108–3117. 6 indexed citations
17.
Sundling, Kaitlin E., Gheorghe Crăciun, Irvin R. Schultz, et al.. (2014). Modeling the endocrine control of vitellogenin production in female rainbow trout. Mathematical Biosciences & Engineering. 11(3). 621–639. 11 indexed citations
18.
Leng, Shuguang, Yushi Liu, Clément Thomas, et al.. (2013). Native American Ancestry Affects the Risk for Gene Methylation in the Lungs of Hispanic Smokers from New Mexico. American Journal of Respiratory and Critical Care Medicine. 188(9). 1110–1116. 20 indexed citations
19.
Leng, Shuguang, Christine A. Stidley, Yushi Liu, et al.. (2011). Genetic Determinants for Promoter Hypermethylation in the Lungs of Smokers: A Candidate Gene-Based Study. Cancer Research. 72(3). 707–715. 21 indexed citations
20.
Bruse, Shannon, Anil K. Sood, Hans Petersen, et al.. (2011). New Mexican Hispanic Smokers Have Lower Odds of Chronic Obstructive Pulmonary Disease and Less Decline in Lung Function Than Non-Hispanic Whites. American Journal of Respiratory and Critical Care Medicine. 184(11). 1254–1260. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026